India: Delhi High Court Grants Temporary Injunction Against Macleods Pharmaceuticals Ltd

In a recent case decided by the Delhi High Court, Justice R.K.Gauba granted temporary injunction in favor of Intas Pharmaceuticals Ltd (hereinafter referred to as the "Plaintiff") restraining the use of its trademark by the Macleods Pharmaceuticals Ltd (hereinafter referred to as the "Defendant"). The Court granted the interim relief as the Plaintiff proved a prima facie case in their favor and the Defendants' use of the mark was phonetically/visually similar to that of the Plaintiff's mark .

Brief Facts of the Case:

The Plaintiff is a company incorporated under the Companies Act and is engaged in the manufacture of medical and other pharmaceuticals products. The Plaintiff got its trademark GABAPIN registered in the year 1997. In May 2016, it came to the knowledge of the Plaintiff that the mark used by the Defendant 'GABAMIN' is phonetically/visually similar to the Plaintiff's mark 'GABAPIN' and is likely to cause confusion in the minds of public.

Accordingly, the Plaintiff filed a civil suit seeking permanent injunction against the Defendant for infringement of its registered trademark "GABAPIN".

Plaintiff's Submission

  1. The Plaintiff produced records before the Court, showing that it had introduced the medicines in the name of GABAPIN ME and GABAPIN NT which is a variation of GABAPIN.
  2. The Plaintiff contended that the Defendant has not shown any document or alleged in any manner to be selling any medicinal product containing the chemical compound "Gabapentin" alone.
  3. In the application for ad interim relief the Plaintiff alleged that it learnt about the medicinal products having been introduced in the market by the Defendant sometime in May 2016 and in the Plaint the Plaintiff mentioned that the Defendant had applied for registration of the mark "GABAMIN" under Class 5 before the Trademark Registry and upon this knowledge the Plaintiff filed its opposition in January 2010 to which the Defendant had failed to file any counter statement.
  4. The Plaintiff further contended that the use of the mark "GABAMIN" and "GABAMIN NT" by the Defendant is phonetically/visually similar to its registered mark and is dishonest and intended to ruin the goodwill and reputation of the Plaintiff.

Defendant's Submission

  1. The products of the Plaintiff and that of the Defendant has different composition and there is no scope for confusion.
  2. The Defendant contended that in its mark GABAMIN the expression GABA is only a prefix and is a derivative of the chemical compound "GABAPENTIN". It is a generic term and monopoly cannot be claimed by the Plaintiff. The rest of the mark is dissimilar and the suffix "MIN" is sufficient to distinguish the two products.
  3. The Defendant further contended that the Plaintiff is guilty of concealment of the fact that it had knowledge about the products of the Defendant since 2010, as the Plaintiff had earlier opposed an application of the Defendant in relation to the mark "GABAMIN".
  4. The Plaintiff is not entitled to equitable relief on account of equitable laches and acquiescence. The Defendants' product has been in the market since a long time, a fact that can be substantiated by their sales report.
  5. The Defendant claims that balance of convenience lies in their favor.

Decision of the Court

The Court started that it is true that neither side can claim exclusive rights to the use of a generic term such as "Gabapentin". The Court finds no substance in the submission of the Defendant that the Plaintiff is guilty of concealment of material facts. The Plaintiff has clearly declared in the pleadings that its product primarily contains the chemical compound "Gabapentin". The two other products later developed had other ingredients, one sold under the mark "GABAPIN ME" being similar to that of the impugned product of the Defendant, both also having as its contents "Methylcobalamin" and the other "GABAPIN NT" being again similar to the other product of the Defendant "GABAMIN NT", each adding the chemical compound "Nortriptylin" to the prime ingredient "Gabapentin". The Court rejected the contention of the Defendant that Plaintiff concealed the facts relating to trademark registration application submitted by the Defendant in 2006.

The Court further observed that filing of an application of registration of a trademark indicates that the applicant only proposes to use the trademark. Hence, it cannot be assumed that the Plaintiff had knowledge of the product being sold in market since 2010. The Court further observed that it is not possible to raise objections on the ground that prefix used therein is generic in nature and it is not permissible for the mark to be split up to compare them.

On these grounds, the Court held that the Plaintiff has made out prima facie case in its favor. The Court allowed the application under Order 39 Rule 1 & 2 of the Code of Civil Procedure and granted the relief of temporary injunction and restrained the Defendants from using the mark "GABAMIN" and / or "GABAMIN NT" or any other words identical or deceptively similar thereto, singularly or in conjunction with any other words or monogram / logo as a trade mark, service mark, trade name, trading style, or in any other manner whatsoever.

However, the Court allowed the use the mark GABAMIN-NOR. But the use of the said mark shall be such that "GABAMIN‟ and "NOR‟ are in the same font and size.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.